This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Glipizide

Read time: 1 mins
Marketing start date: 23 Nov 2024

Summary of product characteristics


Effective Time

20221013

Version

5

Spl Product Data Elements

Glipizide Glipizide GLIPIZIDE GLIPIZIDE ACETYLTRIBUTYL CITRATE ALUMINUM OXIDE AMMONIA BUTYL ALCOHOL FD&C YELLOW NO. 5 FERROSOFERRIC OXIDE HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) HYDROXYPROPYL CELLULOSE, UNSPECIFIED HYPROMELLOSES ISOPROPYL ALCOHOL LACTOSE MONOHYDRATE MAGNESIUM STEARATE METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) POLYETHYLENE GLYCOL, UNSPECIFIED PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE TITANIUM DIOXIDE Yellow Round 2 Glipizide Glipizide GLIPIZIDE GLIPIZIDE ACETYLTRIBUTYL CITRATE AMMONIA BUTYL ALCOHOL FD&C YELLOW NO. 6 FERROSOFERRIC OXIDE HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) HYDROXYPROPYL CELLULOSE, UNSPECIFIED HYPROMELLOSES ISOPROPYL ALCOHOL LACTOSE MONOHYDRATE MAGNESIUM STEARATE METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) POLYETHYLENE GLYCOL, UNSPECIFIED PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE TITANIUM DIOXIDE Orange Round 3 Glipizide Glipizide GLIPIZIDE GLIPIZIDE ACETYLTRIBUTYL CITRATE AMMONIA BUTYL ALCOHOL FERROSOFERRIC OXIDE HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) HYDROXYPROPYL CELLULOSE, UNSPECIFIED HYPROMELLOSES ISOPROPYL ALCOHOL LACTOSE MONOHYDRATE MAGNESIUM STEARATE METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) POLYETHYLENE GLYCOL, UNSPECIFIED PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE White Round 4

Application Number

ANDA203499

Brand Name

Glipizide

Generic Name

Glipizide

Product Ndc

70771-1099

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1098-3 in bottle of 30 tablets Glipizide Tablets, 2.5 mg R x only 30 tablets ZYDUS NDC 70771-1099-3 in bottle of 30 tablets Glipizide Tablets, 5 mg R x only 30 tablets ZYDUS NDC 70771-1100-3 in bottle of 30 tablets Glipizide Tablets, 10 mg R x only 30 tablets ZYDUS Glipizide ER Tablets Glipizide ER Tablets Glipizide ER Tablets

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.